IRWD
NASDAQ · Biotechnology
Ironwood Pharmaceuticals Inc
$4.22
+0.05 (+1.20%)
Open$4.26
Previous Close$4.17
Day High$4.38
Day Low$4.01
52W High$5.78
52W Low$0.53
Volume—
Avg Volume2.60M
Market Cap664.46M
P/E Ratio27.67
EPS$0.11
SectorBiotechnology
Analyst Ratings
Buy
10 analysts
Price Target
+1,125.1% upside
Current
$4.22
$4.22
Target
$51.70
$51.70
$40.79
$51.70 avg
$62.56
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 258.54M | 288.29M | 73.58M |
| Net Income | 20.97M | 21.05M | 12.49M |
| Profit Margin | 8.1% | 7.7% | 17.0% |
| EBITDA | 87.80M | 93.01M | 23.02M |
| Free Cash Flow | — | — | 13.98M |
| Rev Growth | -10.3% | -10.3% | +11.9% |
| Debt/Equity | 0.61 | 0.61 | 0.47 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |